4.52
Cargo Therapeutics Inc Aktie (CRGX) Neueste Nachrichten
What drives CARGO Therapeutics Inc. stock priceOutstanding trading profits - Autocar Professional
CARGO Therapeutics Inc. Stock Analysis and ForecastMassive portfolio appreciation - Autocar Professional
Is CARGO Therapeutics Inc. a good long term investmentExplosive earning power - Autocar Professional
What analysts say about CARGO Therapeutics Inc. stockConsistently superior profits - jammulinksnews.com
How CARGO Therapeutics Inc. stock performs during market volatilityWatchlist Winner Update - Newser
What makes CARGO Therapeutics Inc. stock price move sharplyFree Predictions - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX, OLO, KLG, GNTY on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CARGO Therapeutics, Inc. (NasdaqCRGX), Olo Inc. (NYSEOLO), WK Kellogg Co (NYSEKLG), Guaranty Bancshares, Inc. (NYSEGNTY) - TradingView
Concentra adds CARGO Therapeutics to its biotech buy haul - The Pharma Letter
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $15.00 Consensus PT from Brokerages - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - Defense World
Shareholder Alert: The Ademi Firm investigates whether CARGO Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. (NASDAQ: CRGX) - TradingView
Huge biotech investor buys 4 Bay Area companies on brink of collapse - SFGATE
Evaluating the Fairness of the Concentra Biosciences Acquisition of CARGO Therapeutics: Is There Undervalued Upside? - AInvest
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc.CRGX - Business Wire
Concentra to acquire CARGO Therapeutics for $4.38 per share By Investing.com - Investing.com Nigeria
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right - ADVFN
Concentra Picks Up Cargo In Latest Troubled Biotech Buyout - insights.citeline.com
Why CARGO Therapeutics Stock Is Gaining Today - Benzinga
New Analyst Forecast: $CRGX Given $5.0 Price Target - Quiver Quantitative
CRGX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Concentra Biosciences, LLC agreed to acquire CARGO Therapeutics, Inc. in a tender offer transaction. - MarketScreener
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition - Investing.com Nigeria
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition By Investing.com - Investing.com South Africa
Latham Advises Cargo Therapeutics in Acquisition by Concentra Biosciences - Latham & Watkins LLP
Tang Capital makes bid for 4th Bay Area biotech in 3 months, offering to take out Cargo Therapeutics - The Business Journals
Cargo Therapeutics rises on Concentra Biosciences' buyout deal - TradingView
Concentra Biosciences Acquires Cargo Therapeutics For $4.379 Per Share - Finimize
CARGO Therapeutics Announces Merger with Concentra Biosciences - TipRanks
CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8% - Seeking Alpha
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):